https://stock.noler.com/us/stock/zymergen-inc https://stock.noler.com/us/stock/zymergen-inc/accounts-payable https://stock.noler.com/us/stock/zymergen-inc/accounts-receivable-gross-current https://stock.noler.com/us/stock/zymergen-inc/accretion-expense https://stock.noler.com/us/stock/zymergen-inc/accrued-liabilities-current https://stock.noler.com/us/stock/zymergen-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/zymergen-inc/accumulated-depreciation https://stock.noler.com/us/stock/zymergen-inc/additional-paid-in-capital https://stock.noler.com/us/stock/zymergen-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/zymergen-inc/amortization https://stock.noler.com/us/stock/zymergen-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/zymergen-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/zymergen-inc/basic-shares https://stock.noler.com/us/stock/zymergen-inc/capital-expenditures https://stock.noler.com/us/stock/zymergen-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/zymergen-inc/cash-acquired-in-excess-of-payments-to-acquire-business https://stock.noler.com/us/stock/zymergen-inc/cash-and-equivalents https://stock.noler.com/us/stock/zymergen-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/zymergen-inc/cash-flow-breakdown https://stock.noler.com/us/stock/zymergen-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zymergen-inc/common-stock-value https://stock.noler.com/us/stock/zymergen-inc/comprehensive-income https://stock.noler.com/us/stock/zymergen-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/zymergen-inc/contract-liability https://stock.noler.com/us/stock/zymergen-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/zymergen-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/zymergen-inc/cost-of-revenue https://stock.noler.com/us/stock/zymergen-inc/costs-and-expenses https://stock.noler.com/us/stock/zymergen-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/zymergen-inc/current-assets https://stock.noler.com/us/stock/zymergen-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/zymergen-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/zymergen-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/zymergen-inc/current-liabilities https://stock.noler.com/us/stock/zymergen-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/zymergen-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/zymergen-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/zymergen-inc/deferred-costs https://stock.noler.com/us/stock/zymergen-inc/deferred-income https://stock.noler.com/us/stock/zymergen-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/zymergen-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/zymergen-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/zymergen-inc/deferred-offering-costs https://stock.noler.com/us/stock/zymergen-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/zymergen-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/zymergen-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/zymergen-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/zymergen-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/zymergen-inc/depreciation https://stock.noler.com/us/stock/zymergen-inc/depreciation-and-amortization https://stock.noler.com/us/stock/zymergen-inc/diluted-shares https://stock.noler.com/us/stock/zymergen-inc/dilutive-securities-effect-on-basic-earnings-per-share-other https://stock.noler.com/us/stock/zymergen-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/zymergen-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/zymergen-inc/eps https://stock.noler.com/us/stock/zymergen-inc/eps-basic https://stock.noler.com/us/stock/zymergen-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/zymergen-inc/financing-cash-flow https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/zymergen-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/zymergen-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/zymergen-inc/foreign-pretax-income https://stock.noler.com/us/stock/zymergen-inc/form-d-stocks https://stock.noler.com/us/stock/zymergen-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/zymergen-inc/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/zymergen-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/zymergen-inc/general-and-administrative-expense https://stock.noler.com/us/stock/zymergen-inc/goodwill https://stock.noler.com/us/stock/zymergen-inc/goodwill-acquired https://stock.noler.com/us/stock/zymergen-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/zymergen-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/zymergen-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/zymergen-inc/income-tax https://stock.noler.com/us/stock/zymergen-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/zymergen-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/zymergen-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/zymergen-inc/insider-transactions-preferred https://stock.noler.com/us/stock/zymergen-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/zymergen-inc/interest-expense https://stock.noler.com/us/stock/zymergen-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/zymergen-inc/interest-expense-on-debt https://stock.noler.com/us/stock/zymergen-inc/interest-paid-net https://stock.noler.com/us/stock/zymergen-inc/interest-payable-current https://stock.noler.com/us/stock/zymergen-inc/inventory https://stock.noler.com/us/stock/zymergen-inc/investing-cash-flow https://stock.noler.com/us/stock/zymergen-inc/investment-income-interest https://stock.noler.com/us/stock/zymergen-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/zymergen-inc/lease-and-rental-expense https://stock.noler.com/us/stock/zymergen-inc/lease-cost https://stock.noler.com/us/stock/zymergen-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/zymergen-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/zymergen-inc/lessor-operating-lease-payments-to-be-received https://stock.noler.com/us/stock/zymergen-inc/lessor-operating-lease-payments-to-be-received-four-years https://stock.noler.com/us/stock/zymergen-inc/lessor-operating-lease-payments-to-be-received-next-twelve-months https://stock.noler.com/us/stock/zymergen-inc/lessor-operating-lease-payments-to-be-received-remainder-of-fiscal-year https://stock.noler.com/us/stock/zymergen-inc/lessor-operating-lease-payments-to-be-received-three-years https://stock.noler.com/us/stock/zymergen-inc/lessor-operating-lease-payments-to-be-received-two-years https://stock.noler.com/us/stock/zymergen-inc/long-term-debt https://stock.noler.com/us/stock/zymergen-inc/net-change-in-cash https://stock.noler.com/us/stock/zymergen-inc/net-income https://stock.noler.com/us/stock/zymergen-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/zymergen-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/zymergen-inc/number-of-operating-segments https://stock.noler.com/us/stock/zymergen-inc/number-of-reportable-segments https://stock.noler.com/us/stock/zymergen-inc/operating-cash-flow https://stock.noler.com/us/stock/zymergen-inc/operating-income https://stock.noler.com/us/stock/zymergen-inc/operating-lease-assets https://stock.noler.com/us/stock/zymergen-inc/operating-lease-cost https://stock.noler.com/us/stock/zymergen-inc/operating-lease-liability https://stock.noler.com/us/stock/zymergen-inc/operating-lease-liability-current https://stock.noler.com/us/stock/zymergen-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/zymergen-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/zymergen-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/zymergen-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/zymergen-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/zymergen-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/zymergen-inc/other-current-assets https://stock.noler.com/us/stock/zymergen-inc/other-income https://stock.noler.com/us/stock/zymergen-inc/other-noncash-income-expense https://stock.noler.com/us/stock/zymergen-inc/other-noncurrent-assets https://stock.noler.com/us/stock/zymergen-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/zymergen-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/zymergen-inc/paid-in-capital-other https://stock.noler.com/us/stock/zymergen-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/zymergen-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/zymergen-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/zymergen-inc/payments-for-restructuring https://stock.noler.com/us/stock/zymergen-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/zymergen-inc/preferred-shares-facts https://stock.noler.com/us/stock/zymergen-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zymergen-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/zymergen-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/zymergen-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/zymergen-inc/preferred-stock-value https://stock.noler.com/us/stock/zymergen-inc/prepaid-expense-current https://stock.noler.com/us/stock/zymergen-inc/pretax-income https://stock.noler.com/us/stock/zymergen-inc/pretax-income-domestic https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-issuance-of-secured-debt https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/zymergen-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/zymergen-inc/property-plant-equipment https://stock.noler.com/us/stock/zymergen-inc/public-float https://stock.noler.com/us/stock/zymergen-inc/reclassifications-of-temporary-to-permanent-equity https://stock.noler.com/us/stock/zymergen-inc/repayments-of-secured-debt https://stock.noler.com/us/stock/zymergen-inc/research-and-development https://stock.noler.com/us/stock/zymergen-inc/restricted-cash https://stock.noler.com/us/stock/zymergen-inc/restricted-cash-current https://stock.noler.com/us/stock/zymergen-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/zymergen-inc/restructuring-and-related-cost-cost-incurred-to-date https://stock.noler.com/us/stock/zymergen-inc/restructuring-and-related-cost-expected-cost https://stock.noler.com/us/stock/zymergen-inc/restructuring-and-related-cost-expected-cost-remaining https://stock.noler.com/us/stock/zymergen-inc/restructuring-charges https://stock.noler.com/us/stock/zymergen-inc/restructuring-reserve https://stock.noler.com/us/stock/zymergen-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/zymergen-inc/restructuring-reserve-current https://stock.noler.com/us/stock/zymergen-inc/restructuring-settlement-and-impairment-provisions https://stock.noler.com/us/stock/zymergen-inc/retained-earnings https://stock.noler.com/us/stock/zymergen-inc/revenue https://stock.noler.com/us/stock/zymergen-inc/revenue-from-collaborative-arrangement-excluding-revenue-from-contract-with-customer https://stock.noler.com/us/stock/zymergen-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/zymergen-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/zymergen-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/zymergen-inc/shareholders-equity https://stock.noler.com/us/stock/zymergen-inc/shares-authorized https://stock.noler.com/us/stock/zymergen-inc/shares-issued https://stock.noler.com/us/stock/zymergen-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/zymergen-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/zymergen-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/zymergen-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/zymergen-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/zymergen-inc/stock-based-compensation https://stock.noler.com/us/stock/zymergen-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/zymergen-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/zymergen-inc/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/zymergen-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/zymergen-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/zymergen-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/zymergen-inc/sublease-income https://stock.noler.com/us/stock/zymergen-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zymergen-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/zymergen-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/zymergen-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/zymergen-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/zymergen-inc/taxes-payable-current https://stock.noler.com/us/stock/zymergen-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/zymergen-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/zymergen-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/zymergen-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/zymergen-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/zymergen-inc/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/zymergen-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/zymergen-inc/total-assets https://stock.noler.com/us/stock/zymergen-inc/total-contract-liability https://stock.noler.com/us/stock/zymergen-inc/total-liabilities https://stock.noler.com/us/stock/zymergen-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/zymergen-inc/unbilled-receivables-current https://stock.noler.com/us/stock/zymergen-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/zymergen-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/zymergen-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/zymergen-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/zymergen-inc/variable-lease-cost https://stock.noler.com/us/stock/zymergen-inc/warrants-and-rights-outstanding